THE CRUNCH

Researchers at MinoHealth AI Labs in Accra, Ghana, removed the guardrails on their drug discovery AI model in 2024 and asked it to design toxins instead. The model produced designs for 1,020 proteins and 5,000 small molecules, all scored as likely toxic by software that predicts how poisonous a substance is, with some resembling ricin, a deadly poison. The researchers never made any of them in a lab, and the study was uploaded to the preprint server arXiv in May 2025.

Founder Darlington Akogo told Rest of World the team was shocked by the results, and the exercise raised a pointed question: if someone took designs like these to a company that makes DNA to order, would anyone stop them? That concern is now echoing through African governments, with Kenya's Ministry of Information, Communications and the Digital Economy among those discussing regulation of DNA synthesis providers, according to a senior official there.

The study has travelled far, including discussion within Interpol. Akogo has warned of AI's bioweapons risk at the World Bank and IMF Spring Meetings and over dinner with Bill Gates in 2023, whom he described as "on the fence" at the time. Gates has since issued public warnings of his own, saying in September that AI's ability to empower a bioterrorist "exists today".

There is precedent: in 2022, scientists at a US drug company ran a similar experiment, generating designs for possible chemical weapons. What differs, Akogo said, is that his team used a general purpose LLM trained for biology and drug discovery. Security researchers note that jailbreaking, the process of persuading a model to drop its inbuilt safeguards, takes persistence rather than expertise. The latest models have stronger safeguards around biological misuse, but the UK government's AI Security Institute says even these are not foolproof.

WHAT HAPPENS NEXT

Watch for movement on regulating DNA synthesis providers, the safeguard Akogo and African officials are pushing for, which would gate who can turn AI-generated toxin designs into real biological material.